Skip to Main Content
International Institute for Nanotechnology
Kabiller Prize • News • Events • Employment
  • About
    • Message from the Director
    • Partners
      • Centers & Institutes
      • Research Initiatives
      • Laboratories
      • Government Agencies
      • Academic
      • Industrial
    • Facilities
  • People
    • Executive Council
    • Steering Committee
    • Affiliated Faculty
      • Weinberg College of Arts & Sciences
      • Kellogg School of Management
      • Feinberg School of Medicine
      • McCormick School of Engineering & Applied Science
    • Administration
  • Research
    • NanoMedicine
      • Northwestern University Center of Cancer Nanotechnology Excellence (CCNE)
        • NU-CCNE Project 1
        • NU-CCNE Project 2
        • NU-CCNE Project 3
        • NU-CCNE Oligonucleotide Synthesis and Nanoconstructs Core
      • NTU-Northwestern Institute for Nanomedicine (NNIN)
        • NNIN Executive Committee
    • NanoOncology
      • Ronald and JoAnne Willens Center for Nano Oncology
        • Willens Center Project 1
        • Willens Center Project 2
        • Willens Center Project 3
        • Willens Center Project 4
        • Willens Center Project 5
    • NanoEnvironment
      • Nanotechnology for Universal Clean Air & Water Security (NU-CAWS)
        • NU-CAWS Affiliated Faculty
        • NU-CAWS Research Highlights
    • NanoEnergy
    • NanoMaterials
      • Center of Excellence for Advanced Bioprogrammable Nanomaterials (C-ABN)
        • Thrust 1 - Materials & Methods Development
        • Thrust 2 - Functional Substrates
        • Thrust 3 - Advanced Biosensing
    • Molecular Electronics
    • Security & Defense
  • Education
    • Ryan Graduate Fellowships
    • IIN Postdoctoral Fellowships
    • Frontiers in Nanotechnology Seminar Series
    • Research Experience for Undergraduates (REU)
    • All Scout Nano Day
    • Nano Boot Camp for Clinicians
    • Nanotechnology Town Hall Meetings
  • Industry
    • Nanotechnology Corporate Partners (NCP) Program
    • Small Business Partnership
  • Giving
  • Kabiller Prize
    • Overview
    • Nomination Process
    • About David Kabiller
    • Kabiller Prize Winners
      • 2019 Chad Mirkin
      • 2017 Robert Langer
      • 2015 Joe DeSimone
    • Kabiller Young Investigator Award Winners
      • 2019 Molly Stevens
      • 2017 Liangfang Zhang
      • 2015 Warren Chan
  • News
  • Events
    • 2020 IIN Virtual Symposium
    • Frontiers in Nanotechnology Seminar Series
    • Nano Boot Camp for Clinicians
    • Nanotechnology Town Hall Meetings
  • Employment
    • Assistant, Associate or Full Professor of Nanotechnology
close
  • NanoMedicine
    • Northwestern University Center of Cancer Nanotechnology Excellence (CCNE)
      • NU-CCNE Project 1
      • NU-CCNE Project 2
      • NU-CCNE Project 3
      • NU-CCNE Oligonucleotide Synthesis and Nanoconstructs Core
    • NTU-Northwestern Institute for Nanomedicine (NNIN)
      • NNIN Executive Committee
  • NanoOncology
    • Ronald and JoAnne Willens Center for Nano Oncology
      • Willens Center Project 1
      • Willens Center Project 2
      • Willens Center Project 3
      • Willens Center Project 4
      • Willens Center Project 5
  • NanoEnvironment
    • Nanotechnology for Universal Clean Air & Water Security (NU-CAWS)
      • NU-CAWS Affiliated Faculty
      • NU-CAWS Research Highlights
  • NanoEnergy
  • NanoMaterials
    • Center of Excellence for Advanced Bioprogrammable Nanomaterials (C-ABN)
      • Thrust 1 - Materials & Methods Development
      • Thrust 2 - Functional Substrates
      • Thrust 3 - Advanced Biosensing
  • Molecular Electronics
  • Security & Defense

Project #3

MINT: A TARGETED APPROACH ENABLING IMMUNOLOGIC ERADICATION OF ADVANCED CANCER

Prof. C. Shad Thaxton

Cancer cell growth and immune system function are intimately linked with cholesterol metabolism. Currently, there are no targeted therapies that potently and simultaneously modulate cellular cholesterol in cancer and immune cells. Our lab has developed myeloid inactivating nanoparticle therapy (MINT) that exquisitely targets and reduces cellular cholesterol as a new treatment for cancer that simultaneously activates a robust anti-tumor adaptive immune response.

The objective of this research project is to develop a treatment regimen of MINT and traditional immunotherapies for cancers that do not respond to either therapy alone. We believe that by rational tuning of the cholesterol-mediated pathway connecting cancer and immune cells, we will reveal potent new cancer therapies with reduced side effects.

Signup For Our Newsletter

Sign up for our newsletter to receive information on events, news, and articles.

More Info
  • Privacy Policy
  • Tech Transfer
  • News & Events
  • Contact Us
  • Sitemap
  • Education
  • About Us
  • Nano101
  • Facilities
  • Partners
Follow Us
  • Facebook
  • Twitter
  • LinkedIn
  • Youtube
  • Instagram

Northwestern University

© International Institute for Nanotechnology